Eric A. Hughes
CIK: 0001938678
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Aug 3, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct25.6K shares at avg. $34.88$892K - Aug 3, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct52.7K shares- - Jun 11, 2026GLUE
Monte Rosa Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
25.8K shares- - Mar 5, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct9.5K shares at avg. $31.67$302K - Mar 5, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct19.7K shares- - Mar 4, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct23.3K shares- - Mar 4, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
50.6K shares- - Mar 4, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct11.3K shares at avg. $32.46$366K - Mar 3, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct24.9K shares- - Mar 3, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct12.1K shares at avg. $32.36$391K - Mar 3, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct141.5K shares- - Mar 3, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct68.7K shares at avg. $32.36$2.2M - Jan 27, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
141.5K shares- - Aug 1, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct52.7K shares at avg. $15.16$799K - Aug 1, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct52.7K shares- - Jun 13, 2025GLUE
Monte Rosa Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
30.7K shares- - Mar 5, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
78.6K shares- - Mar 5, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct8.1K shares at avg. $15.91$129K - Mar 4, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct23.3K shares- - Mar 4, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct15.2K shares at avg. $15.73$239K - Mar 4, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct5.2K shares at avg. $15.56$80K - Mar 3, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct24.9K shares- - Mar 3, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct19.7K shares at avg. $16.19$319K - Dec 11, 2024GLUE
Monte Rosa Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
44.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 |  TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 25,578 | $34.88 | $892,051 | Direct |
| Aug 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 52,744 | - | $0 | Direct |
| Jun 11, 2026 |  GLUE Monte Rosa Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 25,800 | - | - | Direct |
| Mar 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 9,533 | $31.67 | $301,895 | Direct |
| Mar 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 19,654 | - | $0 | Direct |
| Mar 4, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 23,251 | - | $0 | Direct |
| Mar 4, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 50,643 | - | - | Direct |
| Mar 4, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 11,277 | $32.46 | $366,102 | Direct |
| Mar 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 24,900 | - | $0 | Direct |
| Mar 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 12,077 | $32.36 | $390,811 | Direct |
| Mar 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 141,478 | - | $0 | Direct |
| Mar 3, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 68,685 | $32.36 | $2,222,640 | Direct |
| Jan 27, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 141,478 | - | - | Direct |
| Aug 1, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 52,742 | $15.16 | $799,437 | Direct |
| Aug 1, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 52,742 | - | - | Direct |
| Jun 13, 2025 | GLUE Monte Rosa Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 30,700 | - | - | Direct |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 78,616 | - | - | Direct |
| Mar 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 8,077 | $15.91 | $128,531 | Direct |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 23,251 | - | - | Direct |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 15,174 | $15.73 | $238,757 | Direct |
| Mar 4, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 5,174 | $15.56 | $80,495 | Direct |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 24,900 | - | - | Direct |
| Mar 3, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 19,726 | $16.19 | $319,275 | Direct |
| Dec 11, 2024 | GLUE Monte Rosa Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 44,200 | - | - | Direct |
1-24 of 24 transactions
About Hughes Eric A
Hughes Eric A (SEC CIK 0001938678) files insider reports with the SEC as Officer of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) and Director of Monte Rosa Therapeutics, Inc. (GLUE).
Signal8 holds 13 ownership filings by Hughes Eric A (1 Form 3, 12 Form 4), filed between Dec 13, 2024 and Aug 5, 2026. Those filings report 24 transactions, from Dec 11, 2024 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hughes Eric A's filings is in TEL AVIV.
Recent filings by Hughes Eric A
- Aug 3, 2026: Open-market sale of TEVA shares (Form 4, code S).
- Aug 3, 2026: Option exercise of TEVA shares (Form 4, code M).
- Jun 11, 2026: Grant or award of GLUE derivative securities (Form 4, code A).
- Mar 5, 2026: Open-market sale of TEVA shares (Form 4, code S).
- Mar 5, 2026: Option exercise of TEVA shares (Form 4, code M).
Other insiders filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
- Bergwerk Dov, Interim Cheif Legal Officer
- Savage Brian, Interim Chief Legal Officer
- MIGNONE ROBERTO, Director
- Weiss Amir, Chief Accounting Officer
- Satchi-Fainaro Ronit, Director
- Lippman Evan, EVP, Business Development